User profiles for "author:Emmanuel Seront"

Seront Emmanuel

Cliniques universitaires Saint Luc
Verified email at saintluc.uclouvain.be
Cited by 1868

Genetic basis and therapies for vascular anomalies

A Queisser, E Seront, LM Boon, M Vikkula - Circulation research, 2021 - Am Heart Assoc
Vascular and lymphatic malformations represent a challenge for clinicians. The identification
of inherited and somatic mutations in important signaling pathways, including the PI3K …

New and emerging targeted therapies for vascular malformations

A Van Damme, E Seront, V Dekeuleneer… - American journal of …, 2020 - Springer
Vascular malformations are inborn errors of vascular morphogenesis and consist of
localized networks of abnormal blood and/or lymphatic vessels with weak endothelial cell …

[HTML][HTML] Theranostic advances in vascular malformations

V Dekeuleneer, E Seront, A Van Damme… - Journal of Investigative …, 2020 - Elsevier
Vascular malformations are subdivided into capillary, lymphatic, venous, arteriovenous, and
mixed malformations, according to the type of affected vessels. Until a few years ago …

Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial

MR Smith, HI Scher, S Sandhu, E Efstathiou… - The Lancet …, 2022 - thelancet.com
Background Metastatic castration-resistant prostate cancers are enriched for DNA repair
gene defects (DRDs) that can be susceptible to synthetic lethality through inhibition of PARP …

[HTML][HTML] Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects

E Boscolo, N Limaye, L Huang… - The Journal of …, 2015 - Am Soc Clin Investig
Venous malformations (VMs) are composed of ectatic veins with scarce smooth muscle cell
coverage. Activating mutations in the endothelial cell tyrosine kinase receptor TIE2 are a …

[HTML][HTML] Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study

J Hammer, E Seront, S Duez, S Dupont… - Orphanet journal of rare …, 2018 - Springer
Background Extensive and complex vascular malformations often cause chronic pain and
severe functional restraint. Conventional treatments, such as surgery and/or sclerotherapy …

Antitumor activity of 7-aminocarboxycoumarin derivatives, a new class of potent inhibitors of lactate influx but not efflux

N Draoui, O Schicke, E Seront, C Bouzin… - Molecular cancer …, 2014 - AACR
High lactate concentration in tumors is associated with bad prognosis. Lactate is released by
glycolytic cells in tumors and recaptured by oxidative cancer cells to feed the tricarboxylic …

[HTML][HTML] Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular …

E Seront, S Rottey, B Sautois, J Kerger, LA D'Hondt… - Annals of oncology, 2012 - Elsevier
Background This phase II study assessed the safety and efficacy of everolimus, an oral
mammalian target of rapamycin inhibitor in advanced transitional carcinoma cell (TCC) after …

Clinical activity and safety of cabozantinib for brain metastases in patients with renal cell carcinoma

L Hirsch, NM Chanza, S Farah, W Xie, R Flippot… - JAMA …, 2021 - jamanetwork.com
Importance Patients with brain metastases from renal cell carcinoma (RCC) have been
underrepresented in clinical trials, and effective systemic therapy is lacking. Cabozantinib …

Venous malformations of the head and neck

E Seront, M Vikkula, LM Boon - Otolaryngologic clinics of North …, 2018 - oto.theclinics.com
With an incidence of approximately 1 in 2,000 to 5,000, venous malformations (VMs)
represent a vascular malformation frequently observed in specialized multidisciplinary …